Dr. Kalinsky on Optical Imaging for HER2+ Breast Cancer
Kevin Kalinsky, MD
Kevin Kalinsky, MD, assistant professor of Medicine at Columbia University Medical Center, discusses the potential advantages of optical imaging for patients with HER2-positive breast cancer.
Some patients with breast cancer are unable to tolerate MRIs, which makes non-invasive optical imaging beneficial, explains Kalinsky. There is no intravenous injection needed, allowing it to be relatively quick and inexpensive.